Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA.

Pharmacogenetics. 1997 Dec;7(6):479-84.

PMID:
9429233
2.
3.

Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.

Suzuki A, Kondo T, Mihara K, Furukori H, Nagashima U, Ono S, Otani K, Kaneko S.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Oct;24(7):1105-13.

PMID:
11131175
4.

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.

Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK.

Neuroscience. 1999 May;90(2):433-45.

PMID:
10215149
5.

Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects.

Bartrés-Faz D, Junqué C, Serra-Grabulosa JM, López-Alomar A, Moya A, Bargalló N, Mercader JM, Moral P, Clemente IC.

Neuroreport. 2002 Jul 2;13(9):1121-5.

PMID:
12151753
6.

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.

Mihara K, Suzuki A, Kondo T, Yasui-Furukori N, Ono S, Otani K, Kaneko S, Inoue Y.

Am J Med Genet. 2001 Apr 8;105(3):271-4.

PMID:
11353448
7.

Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.

Mihara K, Kondo T, Suzuki A, Yasui N, Nagashima U, Ono S, Otani K, Kaneko S.

Psychopharmacology (Berl). 2000 Apr;149(3):246-50.

PMID:
10823405
8.

The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects.

Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvälahti E, Hietala J.

Pharmacogenet Genomics. 2005 Jun;15(6):387-91.

PMID:
15900211
9.

Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.

Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shioduka S, Hamaguchi H, Toru M, Shibuya H.

Alcohol Clin Exp Res. 1998 Jun;22(4):845-8.

PMID:
9660310
10.

The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.

Berggren U, Fahlke C, Aronsson E, Karanti A, Eriksson M, Blennow K, Thelle D, Zetterberg H, Balldin J.

Alcohol Alcohol. 2006 Sep-Oct;41(5):479-85. Epub 2006 Jun 2.

PMID:
16751215
11.

Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome.

Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ.

Pediatr Neurol. 2005 Oct;33(4):272-6.

PMID:
16194726
12.

Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals.

Berggren U, Fahlke C, Berglund KJ, Wadell K, Zetterberg H, Blennow K, Thelle D, Balldin J.

Alcohol Alcohol. 2010 Jan-Feb;45(1):1-5. doi: 10.1093/alcalc/agp041. Epub 2009 Aug 4.

PMID:
19654188
13.

The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics.

Laine TP, Ahonen A, Räsänen P, Pohjalainen T, Tiihonen J, Hietala J.

Alcohol Alcohol. 2001 May-Jun;36(3):262-5.

PMID:
11373265
14.

A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence.

Han DH, Yoon SJ, Sung YH, Lee YS, Kee BS, Lyoo IK, Renshaw PF, Cho SC.

Compr Psychiatry. 2008 Jul-Aug;49(4):387-92. doi: 10.1016/j.comppsych.2008.01.008. Epub 2008 Mar 21.

PMID:
18555060
15.
16.

Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males.

Hallikainen T, Hietala J, Kauhanen J, Pohjalainen T, Syvälahti E, Salonen JT, Tiihonen J.

Am J Med Genet A. 2003 Jun 1;119A(2):152-5.

PMID:
12749054
17.
18.

Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.

Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, Taub M, Montgomery AR, Sheridan PJ, Cull JG.

Pharmacogenetics. 1996 Aug;6(4):297-305.

PMID:
8873216
19.

The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.

Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.

Mov Disord. 2000 Jan;15(1):127-31.

PMID:
10634251
20.

DNA methylation at the putative promoter region of the human dopamine D2 receptor gene.

Popendikyte V, Laurinavicius A, Paterson AD, Macciardi F, Kennedy JL, Petronis A.

Neuroreport. 1999 Apr 26;10(6):1249-55.

PMID:
10363934

Supplemental Content

Support Center